OS Therapies (OST) is a clinical-stage cancer immunotherapy company dedicated to developing a new way of activating the immune system to kill cancers that express HER2 like Osteosarcoma, Breast Cancer, Colorectal Cancer and other solid tumors. With over 30 years of without new treatments in Osteosarcoma, we are first addressing this urgent need for innovative therapies for both kids and adults.
We will then expand our lead candidate’s therapeutic development into Breast, Esophageal, Lung, Ovarian, and Pancreatic cancers.
